Aromatase Inhibitor Drugs Expected to Expand at a Steady CAGR through 2018 – 2026

Press Release

Aromatase inhibitor drugs are used to treat breast cancer by reducing levels of estrogen in blood circulation. These inhibit the enzyme aromatase. Androgens are converted to estrogen by aromatase. Less availability of estrogen reduces the stimulation of the growth of estrogen receptor (ER) positive breast cancer cells. Over 80% of all breast cancers are ER positive. Usage of aromatase inhibitors prevents ovaries from producing estrogen. Hence, these drugs are only used in the treatment of breast cancer in postmenopausal women. Uncontrolled growth of abnormal cells in many parts of the breast such as non-glandular tissue, small sacs that produce milk (lobules), and ducts that carry milk to the nipple is known as breast cancer. The two types of breast cancer are invasive and non-invasive. Invasive breast cancer is characterized by cancerous cells in the lining of the lobules or ducts. Due to invasive cancer cells, the surrounding tissues like skin, connective tissues, and fatty tissues become cancerous. Non-invasive breast cancer is characterized by cancerous cells in lobules or ducts.

Rise in prevalence of breast cancer across the world boosts demand for aromatase inhibitor drugs. According to the Centers for Disease Control and Prevention (CDC), nearly 2,141 men and 236,968 women were diagnosed with breast cancer, and nearly 465 men and 41,211 women succumbed to the disease in the U.S. in 2014. According to the American Cancer Society, breast cancer accounted for 40,610 deaths, and 252,710 new invasive breast cancer and 63,410 non-invasive breast cancer cases were reported in 2017. According to Cancer Research UK, breast cancer accounted for 11,433 deaths in 2014, and 55,122 new cases of invasive breast cancer were registered in the U.K. in 2015. Increase in awareness about cancer drives demand for aromatase inhibitor drugs across the world. Rise in research and development on aromatase inhibitor drugs is attributed to the significant growth of the global aromatase inhibitor drugs market. According to The Pink Initiative, breast cancer accounted for 47,984 female deaths and 187,213 new cases were reported among women in China in 2012.

The global aromatase inhibitor drugs market can be segmented based on product, distribution channel, and region. In terms of product, the market can be categorized into letrozole, exemestane, testolactone, and anastrozole. Based on distribution channel, the global aromatase inhibitor drugs market can be classified into retail pharmacies, online pharmacies, and hospital pharmacies.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/aromatase-inhibitor-drugs-market.html

Geographically, the global aromatase inhibitor drugs market can be categorized into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. North America held the largest market share owing to increase in health care expenditure and rise in prevalence of breast cancer. Europe held the second largest market share in 2017 due to increase in research and development on aromatase inhibitor drugs in the region. High incidence of breast cancer in developing countries and investment by key players in emerging economies with large patient population are anticipated to drive the market in Asia Pacific. The global aromatase inhibitor drugs market in Middle East & Africa is expected to be driven by rise in prevalence of breast cancer. The market in Latin America is expected to grow at a rapid pace during the forecast period from 2018 to 2026 due to increase in awareness about breast cancer among the people.

Key players in the global aromatase inhibitor drugs market include Novartis AG, Bristol-Myers Squibb and Company, AstraZeneca, and Pfizer, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=45039&source=atm

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=45039&source=atm

This post was originally published on Space Market Research


Related Articles